Meyer Balter

5.2k total citations
64 papers, 2.7k citations indexed

About

Meyer Balter is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Meyer Balter has authored 64 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 30 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in Meyer Balter's work include Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers) and Sarcoidosis and Beryllium Toxicity Research (15 papers). Meyer Balter is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers) and Sarcoidosis and Beryllium Toxicity Research (15 papers). Meyer Balter collaborates with scholars based in Canada, United States and Australia. Meyer Balter's co-authors include Jean Bourbeau, Paul Hernandez, Darcy D. Marciniuk, Shawn D. Aaron, Denis E. O’Donnell, Gordon Ford, Alan Kaplan, François Maltais, Roger Goldstein and Rick Hodder and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Meyer Balter

63 papers receiving 2.6k citations

Peers

Countries citing papers authored by Meyer Balter

Since Specialization

Citations

This map shows the geographic impact of Meyer Balter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meyer Balter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meyer Balter more than expected).

Fields of papers citing papers by Meyer Balter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meyer Balter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meyer Balter. The network helps show where Meyer Balter may publish in the future.

Co-authorship network of co-authors of Meyer Balter

This figure shows the co-authorship network connecting the top 25 collaborators of Meyer Balter. A scholar is included among the top collaborators of Meyer Balter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meyer Balter. Meyer Balter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Epidemiology and Survival of Systemic Sclerosis–Sarcoidosis Overlap Syndrome 2023 ·The Journal of Rheumatology ·Megan E. Himmel, Meyer Balter, (unknown), (unknown), (unknown), (unknown), Mohammad Movahedi, Sindhu R. Johnson	2
2	Prognostic Value of Cardiac MRI and FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis 2023 ·Radiology ·(unknown), (unknown), Michael Chan, (unknown), (unknown), Ya Ruth Huo, (unknown), Jordi Broncano, Paaladinesh Thavendiranathan, Matthew D. F. McInnes, (unknown), Meyer Balter, Yasbanoo Moayedi, Ashley Farrell, Kate Hanneman	27
3	Combined FDG PET/MRI versus Standard-of-Care Imaging in the Evaluation of Cardiac Sarcoidosis 2023 ·Radiology Cardiothoracic Imaging ·Constantin Marschner, (unknown), (unknown), (unknown), Paaladinesh Thavendiranathan, Robert M. Iwanochko, Meyer Balter, Yasbanoo Moayedi, Juan Duero Posada, Kate Hanneman	6
4	Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis 2022 ·Radiology ·(unknown), Michael Chan, (unknown), Ashley Farrell, Nayaar Islam, Matthew D. F. McInnes, (unknown), Meyer Balter, Yasbanoo Moayedi, Paaladinesh Thavendiranathan, Ur Metser, Patrick Veit‐Haibach, Kate Hanneman	52
5	Hospitalizations in Sarcoidosis: A Cohort Study of a Universal Healthcare Population 2021 ·Annals of the American Thoracic Society ·Lee Fidler, Andrea S. Gershon, Jolene H. Fisher, Matthew B. Stanbrook, Teresa To, Meyer Balter	6
6	The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study 2021 ·Respiratory Medicine ·(unknown), Alicia K. Gerke, Elyse E. Lower, А. A. Vizel, Deepak Talwar, Irina Strâmbu, (unknown), Jacobo Sellarés, Michiru Sawahata, Ogugua Ndili, Sonoko Nagai, Kiminobu Tanizawa, Marc A. Judson, Florence Jeny, Dominique Valeyre, (unknown), Carlos A.C. Pereira, Meyer Balter, Robert P. Baughman	33
7	Cardiac Sarcoidosis: A Clinical Overview 2021 ·Current Problems in Cardiology ·Ana Carolina Alba, (unknown), Lakshmi Kugathasan, Andrew C.T. Ha, (unknown), Meyer Balter, Álvaro Sosa Liprandi, María Inés Sosa Liprandi	6
8	Epidemiology and health outcomes of sarcoidosis in a universal healthcare population: a cohort study 2019 ·European Respiratory Journal ·Lee Fidler, Meyer Balter, Jolene H. Fisher, Teresa To, Matthew B. Stanbrook, Andrea S. Gershon	41
9	Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence 2019 ·Canadian Journal of Respiratory Critical Care and Sleep Medicine ·Jean Bourbeau, Mohit Bhutani, Paul Hernandez, Shawn D. Aaron, Meyer Balter, Marie-France Beauchesne, Anthony D’Urzo, Roger Goldstein, Alan Kaplan, François Maltais, Don D. Sin, Darcy D. Marciniuk	59
10	Clinical Trial Risk in Chronic Obstructive Pulmonary Disease: The Effects of Drug Class and Inclusion Criteria 2015 ·Respiration ·(unknown), Jayson L. Parker, (unknown), Meyer Balter	5
11	Canadian Practice Assessment in Chronic Obstructive Pulmonary Disease: Respiratory Specialist Physician Perception Versus Patient Reality 2013 ·Canadian Respiratory Journal ·Paul Hernandez, Meyer Balter, Jean Bourbeau, Charles K. Chan, Darcy D. Marciniuk, Shannon L. Walker	30
12	Alpha-1 Antitrypsin Deficiency Targeted Testing and Augmentation Therapy: A Canadian Thoracic Society Clinical Practice Guideline 2012 ·Canadian Respiratory Journal ·(unknown), Paul Hernandez, Meyer Balter, Jean Bourbeau, Kenneth R. Chapman, (unknown), (unknown), François Maltais, (unknown), Donna Goodridge, Charlie Strange, (unknown), (unknown), Stella Muthuri	66
13	Nontuberculous Mycobacterial Infection as a Cause of Difficult-to-Control Asthma 2010 ·CHEST Journal ·Leandro Genehr Fritscher, Theodore K. Marras, (unknown), Carlos Cézar Fritscher, Meyer Balter, Kenneth R. Chapman	19
14	Living with chronic obstructive pulmonary disease: A survey of patients’ knowledge and attitudes 2009 ·Respiratory Medicine ·Paul Hernandez, Meyer Balter, Jean Bourbeau, Rick Hodder	71
15	Counting, analysing and reporting exacerbations of COPD in randomised controlled trials 2007 ·Thorax ·Shawn D. Aaron, Dean Fergusson, Guy B. Marks, Samy Suissa, Katherine L. Vandemheen, Steve Doucette, François Maltais, (unknown), Roger Goldstein, Meyer Balter, D. E. O'Donnell, Mark Fitzgerald	78
16	The Canadian Optimal Therapy of COPD Trial: Design, Organization and Patient Recruitment 2004 ·Canadian Respiratory Journal ·Shawn D. Aaron, Katherine L. Vandemheen, Dean Fergusson, Mark Fitzgerald, François Maltais, Jean Bourbeau, Roger Goldstein, Andrew McIvor, Meyer Balter, Denis E. O’Donnell	19
17	Inhaled Beclomethasone Dipropionate Improves Acoustic Measures of Voice in Patients With Asthma 2001 ·CHEST Journal ·Meyer Balter, Scott Adams, Kenneth R. Chapman	16
18	Large Airway Disease Associated With Inflammatory Bowel Disease 1998 ·CHEST Journal ·(unknown), Ronald F. Grossman, Meyer Balter	90
19	Treatment of allergic bronchopulmonary aspergillosis with inhaled corticosteroids 1992 ·Respiratory Medicine ·Meyer Balter, Anthony S. Rebuck	18
20	Arachidonic Acid Metabolism in Cultured Alveolar Macrophages from Normal, Atopic, and Asthmatic Subjects 1988 ·American Review of Respiratory Disease ·Meyer Balter, William L. Eschenbacher, Marc Peters‐Golden	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact